Aldeyra Therapeutics Inc

NASDAQ:ALDX  
12.50
+0.45 (+3.73%)
Products, Regulatory, Equity Financing / Related

Aldeyra Therapeutics Announces Proposed $125 Mln Public Offering Of Common Stock

Published: 04/27/2021 21:49 GMT
Aldeyra Therapeutics Inc (ALDX) - Aldeyra Therapeutics, Inc. Announces Proposed $125 Million Public Offering of Common Stock.
Aldeyra Therapeutics - Net Proceeds of Offering to Be Used for Preparation of Potential New Drug Application Submission for Lead Compound, Reproxalap.
Aldeyra - Net Proceeds to Also Be Used for Preparations for Commercial Launch of Reproxalap & Subsequent Commercialization of Reproxalap, If Approved.